|
|
Weekly Top Stories
|
Wed, 06 May 2020
|
|
We have 28 articles this week. The week’s biggest highlights are : #Sartorius Closes Acquisition of Selected Assets of #DanaherLifeSciences. #CERUS Announces the Acquisition of #LaboratoriDerivatiOrganiciSpA (LDO) by #OpocrinSpA. #MeridianBioscience Announces Closing of Transaction to Acquire #ExalenzBioscience. #Dascena Secures $50M Series B To Improve Patient Outcomes. #VidaHealth raises $25M to meet increased demand due to COVID-19. #DarioHealth partners with #MediOrbis to bring telemedicine to its mobile disease management platform. #Geisinger Expands Telehealth Services to Assess, Monitor and Triage COVID Patients At-Home |
|
Editor's Choice
|
|
1.
|
How COVID-19 Impact on Hydroxychloroquine Market Report-Industry Share, Size, Growth, Trends, Top leader-Advanz Pharma, Teva Pharmaceutical Industries, Sanofi, Novartis AG, Lupin, Laurus Labs Ltd |
|
2.
|
Covid-19: Some Biopharma Companies Have Seen Market Cap Growth Due to the Pandemic |
|
3.
|
Pharma and Healthcare Social Media Market (Covid-19 Updated) Experiencing Dominant Growth Outlook Till 2026 |
|
4.
|
Exclusive Demand for Diabetic Neuropathic Pain Drug Market Projected to Witness Vigorous Expansion by 2020-2027 by Major innovators like Astellas Pharma, AstraZeneca Plc |
|
5.
|
Specialty Pharmaceutical Market Insights, Size, Share, Trends, Opportunity & with COVID-19 Impact Forecast |
|
Top 10 M&A Transactions
|
|
6.
|
Sartorius Closes Acquisition of Selected Assets of Danaher Life Sciences |
|
7.
|
Meridian Bioscience Announces Closing of Transaction to Acquire Exalenz Bioscience |
|
8.
|
Pressure BioSciences, Through Cannaworx, Inc., Announces Letter of Intent to Acquire SkinScience Labs, Inc. |
|
9.
|
CERUS Announces the Acquisition of Laboratori Derivati Organici SpA (LDO) by Opocrin SpA |
|
10.
|
Amedisys Signs Definitive Agreement to Acquire AseraCare Hospice |
|
11.
|
JCR Pharmaceuticals announces Completion of Acquisition of ArmaGen, Inc. |
|
12.
|
RRS Medical Expands its Secure PHI Transfer Reach with a Strategic Acquisition |
|
13.
|
Supernus to Acquire CNS Portfolio from US WorldMeds |
|
14.
|
Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc. |
|
15.
|
DiscernDx Acquires Luminist Labs to Expand Precision Medicine Solutions for Chronic Diseases |
|
Top 3 Venture Funding
|
|
16.
|
Vida Health Raises $25M to Meet Increased Demand Due to COVID-19 |
|
17.
|
Dascena Secures $50M Series B to Improve Patient Outcomes |
|
18.
|
Alume Biosciences Completes $5.5M Series A Financing |
|
Top 4 Partnerships Announcements
|
|
19.
|
Dariohealth Partners with Mediorbis to Bring Telemedicine to Its Mobile Disease Management Platform |
|
20.
|
Boston Medical, Rimidi Partner to Tackle High-Risk Pregnancy During COVID-19 |
|
21.
|
Geisinger Expands Telehealth Services to Assess, Monitor and Triage COVID Patients At-Home |
|
22.
|
Notable and MDS Foundation Partner on MDS Trials and New Drug Therapies |
|
Read More Corporate Development and M&A Activity |
|
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
|
|
 |
Editor: Ed Francis
Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.
If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073
Or connect with him at  
|
|
OTHER ADVISORIES
|
Advertise with us
We Reach Half Million Decision Makers in: Healthcare · IT · Retail · IndustrialAdvertise with us and reach the right audience. advertise@distilnfo.com |
Contact Us
 5760 Legacy Dr, B3-405, Plano TX 75024
|
 +1 469-270-3311
|
|
DistilINFO Publications
DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.
You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.
View in browser | Advertise | Contact Us
|
|
|
